Mimedx (MDXG) Net Income (QoQ) (2011 - 2024)
Mimedx (MDXG) Net Income (QoQ) (2011 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,094.26 Bn | 68,093.97 Bn | - |
| 2 | Nanobiotix | 1,939.09 Bn | 1,939.02 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.34 Bn | 116.09 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.38 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - |
| 8 | Argenx Se | 56.38 Bn | 51.20 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn |
| 10 | Mimedx | 633.86 Mn | 474.09 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 5,325.00% |
| Jun 30, 2024 | -98.00% |
| Mar 31, 2024 | -90.86% |
| Dec 31, 2023 | 810.71% |
| Sep 30, 2023 | 96.17% |
| Jun 30, 2023 | -164.75% |
| Mar 31, 2023 | -130.94% |
| Dec 31, 2022 | 216.66% |
| Sep 30, 2022 | 22.47% |
| Jun 30, 2022 | -3.61% |
| Mar 31, 2022 | -5,370.85% |
| Dec 31, 2021 | 108.51% |
| Sep 30, 2021 | -31.48% |
| Jun 30, 2021 | 78.78% |
| Mar 31, 2021 | 49.45% |
| Dec 31, 2020 | 14.61% |
| Sep 30, 2020 | -129.35% |
| Jun 30, 2020 | -75.61% |
| Mar 31, 2020 | 35.51% |
| Dec 31, 2019 | -160.39% |